At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
WGS GeneDx Holdings
Market Closed 03-13 16:00:00 EDT
77.78
+0.93
+1.21%
盘后78.10
+0.32+0.41%
19:56 EDT
High80.00Low75.70Vol470.54K
Open78.02D1 Closing76.85Amplitude5.60%
Mkt Cap2.28BTradable Cap1.55BTotal Shares29.29M
T/O36.25MT/O Rate2.36%Tradable Shares19.94M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?
Benzinga_recent_news  ·  03-12 23:07
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?
Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)
TIPRANKS  ·  03-12 20:30
Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)
GeneDx SAVES-Kids study reports USD 80,000 average healthcare cost savings per child after exome and genome testing
Reuters  ·  03-12
GeneDx SAVES-Kids study reports USD 80,000 average healthcare cost savings per child after exome and genome testing
GeneDx to Launch Genetic Testing Program With Zevra Therapeutics to Support Patients With Suspected Niemann-Pick Disease Type C
THOMSON REUTERS  ·  03-10
GeneDx to Launch Genetic Testing Program With Zevra Therapeutics to Support Patients With Suspected Niemann-Pick Disease Type C
Major Insider Moves at GeneDx Holdings Shake Up Investor Buzz
TIPRANKS  ·  03-06
Major Insider Moves at GeneDx Holdings Shake Up Investor Buzz
Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares
Reuters  ·  03-06
Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
prnewswire  ·  03-03
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
A Look At GeneDx Holdings (WGS) Valuation After Breakthrough Device Win And Upgraded 2026 Outlook
Simply Wall St.  ·  03-03
A Look At GeneDx Holdings (WGS) Valuation After Breakthrough Device Win And Upgraded 2026 Outlook
GeneDx Holdings Corp - Secures $100 Mln Term Loan - SEC Filing
THOMSON REUTERS  ·  03-02
GeneDx Holdings Corp - Secures $100 Mln Term Loan - SEC Filing
GeneDx Signs $100 Million Term Loan With Blackstone Credit and Wilmington Trust
Reuters  ·  03-02
GeneDx Signs $100 Million Term Loan With Blackstone Credit and Wilmington Trust
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
GlobeNewswire  ·  02-26
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
Halper Sadeh Probes GeneDx Holdings for Fiduciary Breaches
Reuters  ·  02-26
Halper Sadeh Probes GeneDx Holdings for Fiduciary Breaches
GeneDx to Present at TD Cowen Annual Health Care Conference and Barclays Global Healthcare Conference
Reuters  ·  02-25
GeneDx to Present at TD Cowen Annual Health Care Conference and Barclays Global Healthcare Conference
Wells Fargo Reaffirms Their Buy Rating on GeneDx Holdings (WGS)
TIPRANKS  ·  02-25
Wells Fargo Reaffirms Their Buy Rating on GeneDx Holdings (WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results
Benzinga  ·  02-25
These Analysts Slash Their Forecasts On GeneDx After Q4 Results
Stock Track | GeneDx Holdings Plummets 5.09% Intraday on Multiple Analyst Price Target Cuts
Stock Track  ·  02-24
Stock Track | GeneDx Holdings Plummets 5.09% Intraday on Multiple Analyst Price Target Cuts
GeneDx Holdings (WGS) Gets a Buy from Piper Sandler
TIPRANKS  ·  02-24
GeneDx Holdings (WGS) Gets a Buy from Piper Sandler
GeneDx Holdings Is Maintained at Buy by BTIG
Dow Jones  ·  02-24
GeneDx Holdings Is Maintained at Buy by BTIG
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
Reuters  ·  02-24
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
GeneDx Holdings Corp : Jefferies Cuts Target Price to $150 From $180
THOMSON REUTERS  ·  02-24
GeneDx Holdings Corp : Jefferies Cuts Target Price to $150 From $180

Introduction

Company Name.
GeneDx Holdings
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.
Issue price:
--